Characterizing mouse platelet heterogeneity across diverse disease models using spectral flow cytometry and high-dimensional analysis

Background: Routine platelet assessment based on count and mean platelet volume overlooks heterogeneity of platelet subpopulations that influence disease outcomes. Different platelet subtypes are associated with diverse pathological conditions, highlighting the need to define and characterize them. Human studies face limitations due to interindividual variability and challenges in acquiring matched controls. Moreover, the small and anucleate nature of platelets constrain conventional single-cell analysis approaches. These gaps highlight the need for a mouse-specific flow cytometry panel to enable detailed investigation of platelet heterogeneity in preclinical models. Objectives: To develop and validate a mouse-specific spectral flow cytometry panel integrated with a high-dimensional analysis pipeline for comprehensive characterization of platelet subpopulations and activation states under physiological and pathological conditions. Methods: driven myeloproliferative neoplasms, and breast cancer. Results: mice showed aggregatory and procoagulant fractions, and tumor-bearing mice exhibited increased procoagulant platelets. Across models, platelets displayed upregulation of activation and procoagulant markers. All disease models displayed elevated thiazole orange-positive reticulated platelets. Conclusions: This integrated and scalable workflow provides a robust platform for investigating disease-associated changes in platelet heterogeneity. The PlateletProfiler pipeline is compatible with both mouse and human datasets, supporting broad experimental and translational applications.